These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9748918)

  • 21. The economic burden of prostate cancer, California, 1998.
    Max W; Rice DP; Sung HY; Michel M; Breuer W; Zhang X
    Cancer; 2002 Jun; 94(11):2906-13. PubMed ID: 12115378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receiver operating characteristics of the prostate specific antigen test in an unselected population.
    McLernon DJ; Donnan PT; Gray M; Weller D; Sullivan F
    J Med Screen; 2006; 13(2):102-7. PubMed ID: 16792835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of a worksite migraine intervention program on work productivity, productivity costs, and non-workplace impairment among Spanish postal service employees from an employer perspective.
    Vicente-Herrero T; Burke TA; Laínez MJ
    Curr Med Res Opin; 2004 Nov; 20(11):1805-14. PubMed ID: 15537481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Japanese guideline for prostate cancer screening.
    Hamashima C; Nakayama T; Sagawa M; Saito H; Sobue T
    Jpn J Clin Oncol; 2009 Jun; 39(6):339-51. PubMed ID: 19346535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate cancer. When to offer screening in the primary care setting.
    Gambert SR
    Geriatrics; 2001 Jan; 56(1):22-6, 29-31. PubMed ID: 11196336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate carcinoma among men with human immunodeficiency virus infection.
    Crum NF; Spencer CR; Amling CL
    Cancer; 2004 Jul; 101(2):294-9. PubMed ID: 15241826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practice patterns in screening and management of prostate cancer in elderly men.
    Konety BR; Sharp VJ; Verma M; Williams RD;
    Urology; 2006 Nov; 68(5):1051-6. PubMed ID: 17095076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic evaluation of prostate cancer screening with prostate-specific antigen.
    Imamura T; Yasunaga H
    Int J Urol; 2008 Apr; 15(4):285-8. PubMed ID: 18380812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A model of prostate-specific antigen screening outcomes for low- to high-risk men: information to support informed choices.
    Howard K; Barratt A; Mann GJ; Patel MI
    Arch Intern Med; 2009 Sep; 169(17):1603-10. PubMed ID: 19786680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for prostate cancer in U.S. men ACPM position statement on preventive practice.
    Lim LS; Sherin K;
    Am J Prev Med; 2008 Feb; 34(2):164-70. PubMed ID: 18201648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effectiveness of screening for prostate cancer: a nested case-control study.
    Concato J; Wells CK; Horwitz RI; Penson D; Fincke G; Berlowitz DR; Froehlich G; Blake D; Vickers MA; Gehr GA; Raheb NH; Sullivan G; Peduzzi P
    Arch Intern Med; 2006 Jan; 166(1):38-43. PubMed ID: 16401808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-reported prostate cancer screening in Austria.
    Vutuc C; Waldhoer T; Sevelda P; Micksche M; Haidinger G
    J Med Screen; 2006; 13(3):148-51. PubMed ID: 17007656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of prostate cancer detected by digital rectal examination only.
    Okotie OT; Roehl KA; Han M; Loeb S; Gashti SN; Catalona WJ
    Urology; 2007 Dec; 70(6):1117-20. PubMed ID: 18158030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of prostate cancer screening in Thai elderly.
    Tantiwong A; Soontrapa S; Sujijantrarat P; Vanprapar N; Sawangsak L
    J Med Assoc Thai; 2002 Apr; 85(4):502-8. PubMed ID: 12118499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary care screening for prostate cancer.
    O'Sullivan J
    Clin Excell Nurse Pract; 1998 Sep; 2(5):270-2. PubMed ID: 10455574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The economic impact of false-positive cancer screens.
    Lafata JE; Simpkins J; Lamerato L; Poisson L; Divine G; Johnson CC
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2126-32. PubMed ID: 15598770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Employee response to a company-sponsored program of colorectal and prostate cancer screening.
    Myers RE; Vernon SW; Carpenter AV; Balshem AM; Lewis PG; Wolf TA; Hilbert J; DeFonso LR; Ross EA
    Cancer Detect Prev; 1997; 21(4):380-9. PubMed ID: 9232330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cost-benefit effect of mass screening for prostatic disease on national economy].
    Nakao M; Watanabe H
    Hinyokika Kiyo; 1987 Oct; 33(10):1542-6. PubMed ID: 2451407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.